Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cohbar Inc (CWBR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 151,088
  • Shares Outstanding, K 42,560
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,830 K
  • 36-Month Beta 2.66
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.42

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.90 +35.17%
on 11/20/18
4.22 -7.11%
on 11/30/18
+0.66 (+20.25%)
since 11/14/18
3-Month
2.55 +53.73%
on 11/05/18
4.92 -20.33%
on 09/17/18
-0.72 (-15.52%)
since 09/14/18
52-Week
2.55 +53.73%
on 11/05/18
10.79 -63.67%
on 06/13/18
-1.35 (-25.62%)
since 12/14/17

Most Recent Stories

More News
CohBar Appoints Philippe P. Calais, Pharm.D., Ph.D. as Interim Chief Executive Officer

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that it has appointed Philippe P. Calais,...

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)
Research Report Identifies Equinix, Universal Electronics, LHC Group, Cohbar, Amgen, and Aetna with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Equinix, Inc. (NASDAQ:EQIX),...

AET : 212.70 (+0.33%)
LHCG : 99.24 (-2.37%)
EQIX : 386.90 (-0.62%)
CWBR : 3.92 (+10.42%)
UEIC : 27.72 (-6.41%)
AMGN : 192.07 (-2.76%)
CohBar Founder Dr. Nir Barzilai Awarded the 2018 Fondation IPSEN Longevity Prize

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that company co-founder Dr. Nir Barzilai...

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)
CohBar Provides Update on CB4211 Clinical Trial

CB4211 Phase 1 Clinical Trial Temporarily Suspended to Address Injection Site Reactions

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)
CohBar to Announce 2018 Third Quarter Financial Results and Host Conference Call on November 14, 2018

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that it will release its third quarter...

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)
CohBar Engages LifeSci Advisors as Investor Relations Partner

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that it has engaged LifeSci Advisors...

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)
CohBar, Inc. Announces First Quarter 2018 Financial Results

CohBar, Inc. (NASDAQ:CWBR) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported its financial...

CWBR : 3.92 (+10.42%)
CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange

CohBar, Inc. (NASDAQ:CWBR) and (TSXV:COB.U) ("CohBar" or the "Company") today announced that it has applied to voluntarily delist its common shares from the TSX Venture Exchange ("TSXV").

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)
CohBar, Inc. Announces Fourth Quarter 2017 Financial Results

CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported...

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)
CohBar, Inc. Announces Closing of First Tranche of Private Placement

CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) ("CohBar" or the "Company") is pleased to announce the closing of its first tranche of its previously announced private placement (the "Private Placement") offering...

COB-U.VN : 5.000 (+4.17%)
CWBR : 3.92 (+10.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade CWBR with:

Business Summary

Cohbar, Inc. operates is a biotechnology company. It engaged in the research and development of mitochondria-based therapeutics for the treatment of diseases associated with aging. Cohbar, Inc. is based in Menlo Park, California.

See More

Key Turning Points

2nd Resistance Point 4.26
1st Resistance Point 4.09
Last Price 3.92
1st Support Level 3.65
2nd Support Level 3.38

See More

52-Week High 10.79
Fibonacci 61.8% 7.64
Fibonacci 50% 6.67
Fibonacci 38.2% 5.70
Last Price 3.92
52-Week Low 2.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar